Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakajima, M.
Right arrow Articles by Tanaka, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakajima, M.
Right arrow Articles by Tanaka, M.
NEUROLOGY 2004;62:117-118
© 2004 American Academy of Neurology
Brief Communications

A case of frequently recurring amaurosis fugax with atherothrombotic ophthalmic artery occlusion

M. Nakajima, MD, K. Kimura, MD, K. Minematsu, MD, K. Saito, MD, T. Takada, MD and M. Tanaka, MD

From the Cerebrovascular Division, Department of Medicine (Drs. Nakajima, Kimura, Minematsu, Saito, and Takada) and Department of Ophthalmology (Dr. Tanaka), National Cardiovascular Center, Osaka, Japan.

Address for correspondence and reprint requests to Dr. Makoto Nakajima, Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, 565-8565, Japan; e-mail: nakazima{at}hsp.ncvc.go.jp

A 49-year-old woman with diabetes mellitus and hyperlipidemia experienced frequent transient monocular blindness in the right eye during a 3-week period. Examination revealed atherothrombotic occlusion of the right ophthalmic artery (OA) without embolic sources. After treatment with aspirin, attacks resolved completely. Her symptoms were attributed to microembolism from the occluded OA.

Received July 12, 2003. Accepted in final form September 8, 2003.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.